Aura Biosciences, Inc.
NASDAQ:AURA
10.96 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -76.408 | -58.763 | -35.251 | -22.206 | -24.2 |
| Depreciation & Amortization
| 1.295 | 1.177 | 0.831 | 0.831 | 0.509 |
| Deferred Income Tax
| 1.04 | 0 | 0.014 | 0 | 0.011 |
| Stock Based Compensation
| 8.772 | 6.412 | 2.307 | 0.736 | 0.507 |
| Change In Working Capital
| 4.441 | -3.102 | -0.315 | -3.679 | 2.464 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.04 | 0.34 | 1.054 | -1.721 | 1.043 |
| Other Working Capital
| 5.481 | -3.442 | -1.369 | -1.958 | 1.421 |
| Other Non Cash Items
| -2.987 | -0.325 | 0.004 | -0.003 | 0.043 |
| Operating Cash Flow
| -63.847 | -54.601 | -32.41 | -24.321 | -20.666 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.709 | -1.094 | -2.125 | -0.771 | -2.221 |
| Acquisitions Net
| 0.113 | 0.067 | 0 | 0 | 0 |
| Purchases Of Investments
| -233.651 | -119.784 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 120.397 | 53.009 | 0 | 0 | 0 |
| Other Investing Activites
| -0.113 | -0.067 | 0 | 0 | 0 |
| Investing Cash Flow
| -113.963 | -67.869 | -2.125 | -0.771 | -2.221 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | -0.034 | -0.037 |
| Common Stock Issued
| 97.29 | 8.549 | 78.697 | 10.07 | 39.763 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -0.013 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 94.12 | 87.08 | 87.562 | -0.034 | 39.776 |
| Financing Cash Flow
| 97.29 | 95.629 | 166.259 | 10.036 | 39.726 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -80.52 | -26.841 | 131.724 | -15.056 | 16.839 |
| Cash At End Of Period
| 41.082 | 122.37 | 149.211 | 17.487 | 32.543 |